BMS-986242

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986242, covering 2019-10-08 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer [Phase 1, Phase 2]

See pricing